One of the primary challenges in regulating AI in medical devices is the volume of fragmented standards. The US Food and Drug ...

For amphetamines, the warning is specifically for sudden cardiac death, cardiac abnormalities, abuse, diversion, addiction, or dependency. Amphetamines are central nervous system stimulants, and they ...

A new focus on dermatology, ophthalmology, and gastroenterology will pave ways for many untapped opportunities that Viatris can utilize with its scale and manufacturing power. We believe Viatris is in ...

Finding effective and natural solutions for women’s health can be daunting in today’s fast-paced world. For many women, ...

In July, the FDA granted Breakthrough Therapy designation for cytisinicline for nicotine e-cigarette, or vaping, cessation, ...

As we look at the clinical development program, there's a significant unmet need in NTM lung disease due to current options, having very severe limitations on both efficacy, safety and tolerability ..

Q3 2024 Earnings Call Transcript November 6, 2024 UroGen Pharma Ltd. beats earnings expectations. Reported EPS is $-0.55, expectations were $-0.82. Operator: Good morning, ladies and gentlemen. Thank ...

MannKind will host a conference call and presentation webcast to discuss these results today at 4:30 p.m. Eastern Time. The webcast will be accessible via a link on MannKind’s website. A replay will ...

This study, which has enrolled 275 treatment-naïve patients, both with and without compensated cirrhosis, is designed to evaluate the safety and efficacy of eight weeks of treatment ... In the trial, ...

President-elect Trump is projected to win the popular vote in the presidential election, a feat not achieved by a Republican candidate in 20 years. Current vote counts show Trump surpassing Vice ...

Good afternoon, and welcome to the MannKind Corporation third quarter 2024 financial results earnings call. As a reminder, ...

Avita is still burning cash and the road to profitability depends on clinical readouts for further indications over the next few years, with the use of RECELL currently limited to adult and paediatric ...